NCT05246267View on ClinicalTrials.gov

Dupilumab Treatment Effects in an Ethnically Diverse Population With Chronic Rhinosinusitis With Nasal Polyposis

RecruitingOBSERVATIONAL
Enrollment

60

Participants

Timeline

Start Date

February 15, 2022

Primary Completion Date

June 30, 2026

Study Completion Date

June 30, 2026

Conditions
Chronic Rhinosinusitis With Nasal Polyps
Interventions
BIOLOGICAL

Dupilumab

Standard of care treatment with dupilumab

Trial Locations (1)

10461

RECRUITING

Montefiore Medical Center, The Bronx

All Listed Sponsors
collaborator

Regeneron Pharmaceuticals

INDUSTRY

lead

Montefiore Medical Center

OTHER

NCT05246267 - Dupilumab Treatment Effects in an Ethnically Diverse Population With Chronic Rhinosinusitis With Nasal Polyposis | Biotech Hunter | Biotech Hunter